Hutchmed weighs cancer drug’s supply-chain options amid US-China trade war
Blood-cancer medicine, manufactured in the US, won conditional approval for sale in mainland China last month.

What's Your Reaction?







Chatty News Dec 7, 2024 0 52
Chatty News Nov 18, 2024 0 50
Chatty News Nov 20, 2024 0 43
Chatty News Nov 26, 2024 0 43
Chatty News Feb 18, 2025 0 43
Chatty News Nov 18, 2024 0 27
Chatty News Nov 18, 2024 0 28
Chatty News Nov 18, 2024 0 32
Total Vote: 5
Yes